Absea Biotech
@abseabio.bsky.social
Absea Biotechnology | Empowering protein science
14,000+ recombinant proteins & 11,000+ monoclonal antibodies covering 70% of the human proteome.
Germany-USA-China
https://www.absea.bio/index.html
14,000+ recombinant proteins & 11,000+ monoclonal antibodies covering 70% of the human proteome.
Germany-USA-China
https://www.absea.bio/index.html
Pinned
Absea Biotech
@abseabio.bsky.social
· Sep 4
A novel hybrid high speed mass spectrometer allows rapid translation from biomarker candidates to targeted clinical tests using 15N labeled proteins
Recent developments in affinity binder or mass spectrometry (MS)-based plasma proteomics
are now producing panels of potential biomarker candidates for diagnosis or prognosis.
However, clinical valida...
www.mcponline.org
New in MCP: Absea’s ¹⁵N protein standards supported multi-peptide quantification in patient plasma (ALD panel).
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).
Read more here: www.mcponline.org/article/S153...
#Proteomics#MassSpec mannlab.bsky.social
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).
Read more here: www.mcponline.org/article/S153...
#Proteomics#MassSpec mannlab.bsky.social
Parkinson’s disease is rising with aging populations, highlighting the need for reliable biomarkers.
For researchers studying PD, Absea developed validated reagents for α-synuclein, LRRK2, DJ-1, PINK1 & Parkin to help advance assay development and biomarker research.
Get in contact with us 👇
For researchers studying PD, Absea developed validated reagents for α-synuclein, LRRK2, DJ-1, PINK1 & Parkin to help advance assay development and biomarker research.
Get in contact with us 👇
November 25, 2025 at 10:41 AM
Parkinson’s disease is rising with aging populations, highlighting the need for reliable biomarkers.
For researchers studying PD, Absea developed validated reagents for α-synuclein, LRRK2, DJ-1, PINK1 & Parkin to help advance assay development and biomarker research.
Get in contact with us 👇
For researchers studying PD, Absea developed validated reagents for α-synuclein, LRRK2, DJ-1, PINK1 & Parkin to help advance assay development and biomarker research.
Get in contact with us 👇
Working on neural IF?
We’ve been developing #antibodies with careful epitope choices to help with tissue penetration and background issues.
Recently the Fornasiero Laboratory (U. Göttingen - UMG) validated 85 of them.
Results? High specificity and low background in rat neurons.
See the data 👇
We’ve been developing #antibodies with careful epitope choices to help with tissue penetration and background issues.
Recently the Fornasiero Laboratory (U. Göttingen - UMG) validated 85 of them.
Results? High specificity and low background in rat neurons.
See the data 👇
November 20, 2025 at 10:56 AM
Working on neural IF?
We’ve been developing #antibodies with careful epitope choices to help with tissue penetration and background issues.
Recently the Fornasiero Laboratory (U. Göttingen - UMG) validated 85 of them.
Results? High specificity and low background in rat neurons.
See the data 👇
We’ve been developing #antibodies with careful epitope choices to help with tissue penetration and background issues.
Recently the Fornasiero Laboratory (U. Göttingen - UMG) validated 85 of them.
Results? High specificity and low background in rat neurons.
See the data 👇
Halfway through #HUPO2025 in Toronto.
Philip and Clément have been exchanging ideas with peers on protein standards, ¹⁵N-labeled proteins, workflows, reproducibility, and more.
There’s still a chance to catch them at Booth 204!
#Proteomics #teammassspec
Philip and Clément have been exchanging ideas with peers on protein standards, ¹⁵N-labeled proteins, workflows, reproducibility, and more.
There’s still a chance to catch them at Booth 204!
#Proteomics #teammassspec
November 11, 2025 at 4:54 PM
Halfway through #HUPO2025 in Toronto.
Philip and Clément have been exchanging ideas with peers on protein standards, ¹⁵N-labeled proteins, workflows, reproducibility, and more.
There’s still a chance to catch them at Booth 204!
#Proteomics #teammassspec
Philip and Clément have been exchanging ideas with peers on protein standards, ¹⁵N-labeled proteins, workflows, reproducibility, and more.
There’s still a chance to catch them at Booth 204!
#Proteomics #teammassspec
Day 1 at #HUPO2025 in Toronto.
Philip (SVP) and Clément (Associate Director, Proteomics) are already talking with peers about recombinant proteins, antibodies, proteome libraries, and ¹⁵N-labeled proteins — with a focus on reproducibility in #proteomics.
DM us or find them at Booth #204!
Philip (SVP) and Clément (Associate Director, Proteomics) are already talking with peers about recombinant proteins, antibodies, proteome libraries, and ¹⁵N-labeled proteins — with a focus on reproducibility in #proteomics.
DM us or find them at Booth #204!
November 9, 2025 at 5:48 PM
Day 1 at #HUPO2025 in Toronto.
Philip (SVP) and Clément (Associate Director, Proteomics) are already talking with peers about recombinant proteins, antibodies, proteome libraries, and ¹⁵N-labeled proteins — with a focus on reproducibility in #proteomics.
DM us or find them at Booth #204!
Philip (SVP) and Clément (Associate Director, Proteomics) are already talking with peers about recombinant proteins, antibodies, proteome libraries, and ¹⁵N-labeled proteins — with a focus on reproducibility in #proteomics.
DM us or find them at Booth #204!
🧪 Reproducible IP starts with reliable reagents.
Absea® Anti-HA beads (MB-301) — benchmarked vs top brands by IP-WB and IP-MS:
• capture comparable
• cleaner elutions, less antibody carryover
• ~10% higher target:total iBAQ.
Connect with us for data & protocols.
#Proteomics #IPMS
Absea® Anti-HA beads (MB-301) — benchmarked vs top brands by IP-WB and IP-MS:
• capture comparable
• cleaner elutions, less antibody carryover
• ~10% higher target:total iBAQ.
Connect with us for data & protocols.
#Proteomics #IPMS
November 6, 2025 at 10:41 AM
🧪 Reproducible IP starts with reliable reagents.
Absea® Anti-HA beads (MB-301) — benchmarked vs top brands by IP-WB and IP-MS:
• capture comparable
• cleaner elutions, less antibody carryover
• ~10% higher target:total iBAQ.
Connect with us for data & protocols.
#Proteomics #IPMS
Absea® Anti-HA beads (MB-301) — benchmarked vs top brands by IP-WB and IP-MS:
• capture comparable
• cleaner elutions, less antibody carryover
• ~10% higher target:total iBAQ.
Connect with us for data & protocols.
#Proteomics #IPMS
Absea will be in Toronto for HUPO 2025 (Nov 9–13)!
Philip (SVP) and Clément (Assoc. Dir., Proteomics) will be at Booth 204 to connect with peers and share insights on proteomics workflows.
If you’re attending, stop by or DM to schedule a chat!
#HUPO2025 #Proteomics
Philip (SVP) and Clément (Assoc. Dir., Proteomics) will be at Booth 204 to connect with peers and share insights on proteomics workflows.
If you’re attending, stop by or DM to schedule a chat!
#HUPO2025 #Proteomics
November 4, 2025 at 10:43 AM
Absea will be in Toronto for HUPO 2025 (Nov 9–13)!
Philip (SVP) and Clément (Assoc. Dir., Proteomics) will be at Booth 204 to connect with peers and share insights on proteomics workflows.
If you’re attending, stop by or DM to schedule a chat!
#HUPO2025 #Proteomics
Philip (SVP) and Clément (Assoc. Dir., Proteomics) will be at Booth 204 to connect with peers and share insights on proteomics workflows.
If you’re attending, stop by or DM to schedule a chat!
#HUPO2025 #Proteomics
Great to be in Vienna for BIO-Europe 2025.
Philip (SVP) and Crystal (Sales & Product Spec) from Absea are connecting with peers across biotech to share insights and discuss new collaboration opportunities.
If you’re attending and would like to connect, our DMs are open!
#BIOEurope
Philip (SVP) and Crystal (Sales & Product Spec) from Absea are connecting with peers across biotech to share insights and discuss new collaboration opportunities.
If you’re attending and would like to connect, our DMs are open!
#BIOEurope
November 3, 2025 at 12:30 PM
Great to be in Vienna for BIO-Europe 2025.
Philip (SVP) and Crystal (Sales & Product Spec) from Absea are connecting with peers across biotech to share insights and discuss new collaboration opportunities.
If you’re attending and would like to connect, our DMs are open!
#BIOEurope
Philip (SVP) and Crystal (Sales & Product Spec) from Absea are connecting with peers across biotech to share insights and discuss new collaboration opportunities.
If you’re attending and would like to connect, our DMs are open!
#BIOEurope
Autoantibodies (p53, SOX2, NY-ESO-1, MAGE) can appear early and persist — the immune system’s first signal of cancer.
Absea now provides high-purity human recombinant proteins with batch stability and strict quality control, supporting assay development & validation.
Message us: [email protected]
Absea now provides high-purity human recombinant proteins with batch stability and strict quality control, supporting assay development & validation.
Message us: [email protected]
October 30, 2025 at 10:39 AM
Autoantibodies (p53, SOX2, NY-ESO-1, MAGE) can appear early and persist — the immune system’s first signal of cancer.
Absea now provides high-purity human recombinant proteins with batch stability and strict quality control, supporting assay development & validation.
Message us: [email protected]
Absea now provides high-purity human recombinant proteins with batch stability and strict quality control, supporting assay development & validation.
Message us: [email protected]
Absea will be in Vienna for #BIOEurope, Nov 3–5.
Our SVP and Sales & Product Spec will take part in discussions across the biotech value chain, focusing on collaboration and research impact.
If you're attending let's connect! We still have a few 1:1 meeting slots available — DMs open.
Our SVP and Sales & Product Spec will take part in discussions across the biotech value chain, focusing on collaboration and research impact.
If you're attending let's connect! We still have a few 1:1 meeting slots available — DMs open.
October 28, 2025 at 10:37 AM
Absea will be in Vienna for #BIOEurope, Nov 3–5.
Our SVP and Sales & Product Spec will take part in discussions across the biotech value chain, focusing on collaboration and research impact.
If you're attending let's connect! We still have a few 1:1 meeting slots available — DMs open.
Our SVP and Sales & Product Spec will take part in discussions across the biotech value chain, focusing on collaboration and research impact.
If you're attending let's connect! We still have a few 1:1 meeting slots available — DMs open.
🔬 Meet Marco Hennrich, our Senior Scientist at Absea!
🎓PhD from @utrechtuniversity.bsky.social
He builds integrated platforms for life sciences ✅
Turning complex biology into reproducible insights
From aging stem cells to lipid transport proteins, Marco makes science clear 👏
#Proteomics
🎓PhD from @utrechtuniversity.bsky.social
He builds integrated platforms for life sciences ✅
Turning complex biology into reproducible insights
From aging stem cells to lipid transport proteins, Marco makes science clear 👏
#Proteomics
October 23, 2025 at 9:42 AM
🔬 Meet Marco Hennrich, our Senior Scientist at Absea!
🎓PhD from @utrechtuniversity.bsky.social
He builds integrated platforms for life sciences ✅
Turning complex biology into reproducible insights
From aging stem cells to lipid transport proteins, Marco makes science clear 👏
#Proteomics
🎓PhD from @utrechtuniversity.bsky.social
He builds integrated platforms for life sciences ✅
Turning complex biology into reproducible insights
From aging stem cells to lipid transport proteins, Marco makes science clear 👏
#Proteomics
CNHUPO 2025 is underway in Guangzhou!
Our SVP Philip Lössl and Marketing Dir. Joy Zhou are meeting peers, including @fan-liu.bsky.social(Absea SAB), and following inspiring sessions across the proteomics community.
Great to see Absea featured in @mannlab.bsky.social. presentation.
#teammassspec
Our SVP Philip Lössl and Marketing Dir. Joy Zhou are meeting peers, including @fan-liu.bsky.social(Absea SAB), and following inspiring sessions across the proteomics community.
Great to see Absea featured in @mannlab.bsky.social. presentation.
#teammassspec
October 13, 2025 at 12:09 PM
CNHUPO 2025 is underway in Guangzhou!
Our SVP Philip Lössl and Marketing Dir. Joy Zhou are meeting peers, including @fan-liu.bsky.social(Absea SAB), and following inspiring sessions across the proteomics community.
Great to see Absea featured in @mannlab.bsky.social. presentation.
#teammassspec
Our SVP Philip Lössl and Marketing Dir. Joy Zhou are meeting peers, including @fan-liu.bsky.social(Absea SAB), and following inspiring sessions across the proteomics community.
Great to see Absea featured in @mannlab.bsky.social. presentation.
#teammassspec
New in @natgenet.nature.com: “A standardized framework for circulating blood proteomics” — co-authored by our SVP, Philip Lössl.
Recommends pooled plasma refs + isotope-labeled protein spike-ins.
Thoughts on adoption?
Learn more about👇
#Proteomics #15N #teammassspec
Recommends pooled plasma refs + isotope-labeled protein spike-ins.
Thoughts on adoption?
Learn more about👇
#Proteomics #15N #teammassspec
October 9, 2025 at 9:35 AM
New in @natgenet.nature.com: “A standardized framework for circulating blood proteomics” — co-authored by our SVP, Philip Lössl.
Recommends pooled plasma refs + isotope-labeled protein spike-ins.
Thoughts on adoption?
Learn more about👇
#Proteomics #15N #teammassspec
Recommends pooled plasma refs + isotope-labeled protein spike-ins.
Thoughts on adoption?
Learn more about👇
#Proteomics #15N #teammassspec
Day 1 at the Westlake Symposium for AI Proteomics & Virtual Cell!
Philip Lössl (our SVP) already chaired a panel — excited to connect with peers and discuss AI-driven proteomics.
Attending? Reach out, we’d love to chat!
#Proteomics #LifeSciences #Ai #teammassspec
Philip Lössl (our SVP) already chaired a panel — excited to connect with peers and discuss AI-driven proteomics.
Attending? Reach out, we’d love to chat!
#Proteomics #LifeSciences #Ai #teammassspec
October 8, 2025 at 11:51 AM
Day 1 at the Westlake Symposium for AI Proteomics & Virtual Cell!
Philip Lössl (our SVP) already chaired a panel — excited to connect with peers and discuss AI-driven proteomics.
Attending? Reach out, we’d love to chat!
#Proteomics #LifeSciences #Ai #teammassspec
Philip Lössl (our SVP) already chaired a panel — excited to connect with peers and discuss AI-driven proteomics.
Attending? Reach out, we’d love to chat!
#Proteomics #LifeSciences #Ai #teammassspec
Back-to-back proteomics in China.
After Westlake (Oct 8–10), Absea is heading to CNHUPO 2025 in Guangzhou (Oct 11–14).
Philip Lössl (SVP) & Joy Zhou (Marketing Dir.)will represent our team
Looking forward to connecting — DMs open for 1:1s!
#CNHUPO2025 #Proteomics #Biotech #Conference
After Westlake (Oct 8–10), Absea is heading to CNHUPO 2025 in Guangzhou (Oct 11–14).
Philip Lössl (SVP) & Joy Zhou (Marketing Dir.)will represent our team
Looking forward to connecting — DMs open for 1:1s!
#CNHUPO2025 #Proteomics #Biotech #Conference
October 7, 2025 at 9:42 AM
Back-to-back proteomics in China.
After Westlake (Oct 8–10), Absea is heading to CNHUPO 2025 in Guangzhou (Oct 11–14).
Philip Lössl (SVP) & Joy Zhou (Marketing Dir.)will represent our team
Looking forward to connecting — DMs open for 1:1s!
#CNHUPO2025 #Proteomics #Biotech #Conference
After Westlake (Oct 8–10), Absea is heading to CNHUPO 2025 in Guangzhou (Oct 11–14).
Philip Lössl (SVP) & Joy Zhou (Marketing Dir.)will represent our team
Looking forward to connecting — DMs open for 1:1s!
#CNHUPO2025 #Proteomics #Biotech #Conference
ECDC: ~317,000 chikungunya cases in 2025 (Aug 2025).
Absea® Recombinant CHIKV E2 Protein (PQ-4086) is a reliable antigen standard that:
• Preserves E2 structure
• Supports assay specificity
• Speeds IVD development
Reach out for samples and technical info! 📩
#chikungunya #biotech #LifeSciences
Absea® Recombinant CHIKV E2 Protein (PQ-4086) is a reliable antigen standard that:
• Preserves E2 structure
• Supports assay specificity
• Speeds IVD development
Reach out for samples and technical info! 📩
#chikungunya #biotech #LifeSciences
October 2, 2025 at 9:41 AM
ECDC: ~317,000 chikungunya cases in 2025 (Aug 2025).
Absea® Recombinant CHIKV E2 Protein (PQ-4086) is a reliable antigen standard that:
• Preserves E2 structure
• Supports assay specificity
• Speeds IVD development
Reach out for samples and technical info! 📩
#chikungunya #biotech #LifeSciences
Absea® Recombinant CHIKV E2 Protein (PQ-4086) is a reliable antigen standard that:
• Preserves E2 structure
• Supports assay specificity
• Speeds IVD development
Reach out for samples and technical info! 📩
#chikungunya #biotech #LifeSciences
Heads up, #Proteomics Community! 📢
We're sending our team to the Westlake Symposium for AI Proteomics & Virtual Cell (Oct 8–9).
Participants include Tao Chen (CEO), Philip Lössl (SVP), and Joy Zhou (Marketing Dir.).
Here to exchange ideas and connect, DM us if you'd like to organise a 1:1!
We're sending our team to the Westlake Symposium for AI Proteomics & Virtual Cell (Oct 8–9).
Participants include Tao Chen (CEO), Philip Lössl (SVP), and Joy Zhou (Marketing Dir.).
Here to exchange ideas and connect, DM us if you'd like to organise a 1:1!
September 30, 2025 at 9:38 AM
Heads up, #Proteomics Community! 📢
We're sending our team to the Westlake Symposium for AI Proteomics & Virtual Cell (Oct 8–9).
Participants include Tao Chen (CEO), Philip Lössl (SVP), and Joy Zhou (Marketing Dir.).
Here to exchange ideas and connect, DM us if you'd like to organise a 1:1!
We're sending our team to the Westlake Symposium for AI Proteomics & Virtual Cell (Oct 8–9).
Participants include Tao Chen (CEO), Philip Lössl (SVP), and Joy Zhou (Marketing Dir.).
Here to exchange ideas and connect, DM us if you'd like to organise a 1:1!
Summer’s wrapping up!
Our team swapped pipettes for plates and slides for stories across two September team days:
one exploring Schorfheide, another enjoying an evening picnic.
Plenty of catching up, some quick decisions, and now ready for autumn experiments!
#Teamwork #AutumnVibes
Our team swapped pipettes for plates and slides for stories across two September team days:
one exploring Schorfheide, another enjoying an evening picnic.
Plenty of catching up, some quick decisions, and now ready for autumn experiments!
#Teamwork #AutumnVibes
September 25, 2025 at 9:36 AM
Summer’s wrapping up!
Our team swapped pipettes for plates and slides for stories across two September team days:
one exploring Schorfheide, another enjoying an evening picnic.
Plenty of catching up, some quick decisions, and now ready for autumn experiments!
#Teamwork #AutumnVibes
Our team swapped pipettes for plates and slides for stories across two September team days:
one exploring Schorfheide, another enjoying an evening picnic.
Plenty of catching up, some quick decisions, and now ready for autumn experiments!
#Teamwork #AutumnVibes
Testing pan-allelic enrichment in AML PBMCs with Absea MB-081 beads.
✔️ matched competitors for peptide yield and neoantigen IDs
✔️ motifs remained stable
✔️ beads maintained performance after >12 months’ storage.
RUO.
Contact [email protected] or see datasheets on: www.absea.bio/product-deta...
✔️ matched competitors for peptide yield and neoantigen IDs
✔️ motifs remained stable
✔️ beads maintained performance after >12 months’ storage.
RUO.
Contact [email protected] or see datasheets on: www.absea.bio/product-deta...
September 23, 2025 at 9:48 AM
Testing pan-allelic enrichment in AML PBMCs with Absea MB-081 beads.
✔️ matched competitors for peptide yield and neoantigen IDs
✔️ motifs remained stable
✔️ beads maintained performance after >12 months’ storage.
RUO.
Contact [email protected] or see datasheets on: www.absea.bio/product-deta...
✔️ matched competitors for peptide yield and neoantigen IDs
✔️ motifs remained stable
✔️ beads maintained performance after >12 months’ storage.
RUO.
Contact [email protected] or see datasheets on: www.absea.bio/product-deta...
📢 New paper co-authored by our SAB member Bruce Stillman (cshlnews.bsky.social) in Nature SMB delves into how ORC, Cdc6, Cdt1 & MCM2-7 license DNA replication origins — tying structural and biochemical work to genome-stability implications.
Read more here: www.nature.com/articles/s41...
Read more here: www.nature.com/articles/s41...
Mechanisms for licensing origins of DNA replication in eukaryotic cells - Nature Structural & Molecular Biology
Here, the authors comprehensively discuss the different mechanisms for origin licensing in yeast and human cells. Importantly, they present intuitive videos illustrating such mechanisms with unprecede...
www.nature.com
September 18, 2025 at 9:58 AM
📢 New paper co-authored by our SAB member Bruce Stillman (cshlnews.bsky.social) in Nature SMB delves into how ORC, Cdc6, Cdt1 & MCM2-7 license DNA replication origins — tying structural and biochemical work to genome-stability implications.
Read more here: www.nature.com/articles/s41...
Read more here: www.nature.com/articles/s41...
How do you measure “N” in the AT(N) Alzheimer’s framework? t-tau? Too much from peripheral Big-tau.
NfL? Not AD-specific.
BD-tau offers a more specific blood readout. Absea’s new BD-Tau125 antibody pinpoints the exon 4–5 junction, detecting brain-derived tau with high specificity.
Details below 👇
NfL? Not AD-specific.
BD-tau offers a more specific blood readout. Absea’s new BD-Tau125 antibody pinpoints the exon 4–5 junction, detecting brain-derived tau with high specificity.
Details below 👇
September 16, 2025 at 11:28 AM
How do you measure “N” in the AT(N) Alzheimer’s framework? t-tau? Too much from peripheral Big-tau.
NfL? Not AD-specific.
BD-tau offers a more specific blood readout. Absea’s new BD-Tau125 antibody pinpoints the exon 4–5 junction, detecting brain-derived tau with high specificity.
Details below 👇
NfL? Not AD-specific.
BD-tau offers a more specific blood readout. Absea’s new BD-Tau125 antibody pinpoints the exon 4–5 junction, detecting brain-derived tau with high specificity.
Details below 👇
Our CEO, Tao Chen, will present “Synthetic and interaction proteomics for systems aging biology” at the Stem Cell, Aging, and Rejuvenation session — Cold Spring Harbor Asia.
🗓 Tue, Sept 16 — 19:00 CEST
Want to follow the session or connect afterward? DM us!
#proteomics #aging
🗓 Tue, Sept 16 — 19:00 CEST
Want to follow the session or connect afterward? DM us!
#proteomics #aging
September 11, 2025 at 9:43 AM
Our CEO, Tao Chen, will present “Synthetic and interaction proteomics for systems aging biology” at the Stem Cell, Aging, and Rejuvenation session — Cold Spring Harbor Asia.
🗓 Tue, Sept 16 — 19:00 CEST
Want to follow the session or connect afterward? DM us!
#proteomics #aging
🗓 Tue, Sept 16 — 19:00 CEST
Want to follow the session or connect afterward? DM us!
#proteomics #aging
MTBR-tau243 — a disease-specific Alzheimer’s biomarker that tracks NFT burden.
Unlike some p-tau measures, it rises through disease stages. Absea’s mAbs (ELISA epitope mapping) enable sensitive CSF & plasma detection for staging, monitoring & trials.
Connect with us or visit: www.absea.bio !
Unlike some p-tau measures, it rises through disease stages. Absea’s mAbs (ELISA epitope mapping) enable sensitive CSF & plasma detection for staging, monitoring & trials.
Connect with us or visit: www.absea.bio !
September 9, 2025 at 9:38 AM
MTBR-tau243 — a disease-specific Alzheimer’s biomarker that tracks NFT burden.
Unlike some p-tau measures, it rises through disease stages. Absea’s mAbs (ELISA epitope mapping) enable sensitive CSF & plasma detection for staging, monitoring & trials.
Connect with us or visit: www.absea.bio !
Unlike some p-tau measures, it rises through disease stages. Absea’s mAbs (ELISA epitope mapping) enable sensitive CSF & plasma detection for staging, monitoring & trials.
Connect with us or visit: www.absea.bio !
New in MCP: Absea’s ¹⁵N protein standards supported multi-peptide quantification in patient plasma (ALD panel).
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).
Read more here: www.mcponline.org/article/S153...
#Proteomics#MassSpec mannlab.bsky.social
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).
Read more here: www.mcponline.org/article/S153...
#Proteomics#MassSpec mannlab.bsky.social
A novel hybrid high speed mass spectrometer allows rapid translation from biomarker candidates to targeted clinical tests using 15N labeled proteins
Recent developments in affinity binder or mass spectrometry (MS)-based plasma proteomics
are now producing panels of potential biomarker candidates for diagnosis or prognosis.
However, clinical valida...
www.mcponline.org
September 4, 2025 at 9:57 AM
New in MCP: Absea’s ¹⁵N protein standards supported multi-peptide quantification in patient plasma (ALD panel).
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).
Read more here: www.mcponline.org/article/S153...
#Proteomics#MassSpec mannlab.bsky.social
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).
Read more here: www.mcponline.org/article/S153...
#Proteomics#MassSpec mannlab.bsky.social
For Tau research, breadth and specificity matter.
Absea's antibody toolkit targets >50 site-specific pTau isoforms (not just p-Tau181/217 but rare ones like p-Tau205), all with mapped epitopes and assay validation.
A comprehensive resource for reliable results.
Let’s get in touch!
Absea's antibody toolkit targets >50 site-specific pTau isoforms (not just p-Tau181/217 but rare ones like p-Tau205), all with mapped epitopes and assay validation.
A comprehensive resource for reliable results.
Let’s get in touch!
September 2, 2025 at 9:36 AM
For Tau research, breadth and specificity matter.
Absea's antibody toolkit targets >50 site-specific pTau isoforms (not just p-Tau181/217 but rare ones like p-Tau205), all with mapped epitopes and assay validation.
A comprehensive resource for reliable results.
Let’s get in touch!
Absea's antibody toolkit targets >50 site-specific pTau isoforms (not just p-Tau181/217 but rare ones like p-Tau205), all with mapped epitopes and assay validation.
A comprehensive resource for reliable results.
Let’s get in touch!